Genomic Sequencing Results Disclosure in Diverse and Medically Underserved Populations: Themes, Challenges, and Strategies from the CSER Consortium
- PMID: 33805616
- PMCID: PMC7998798
- DOI: 10.3390/jpm11030202
Genomic Sequencing Results Disclosure in Diverse and Medically Underserved Populations: Themes, Challenges, and Strategies from the CSER Consortium
Abstract
Genomic sequencing results need to be effectively communicated across all populations and practice settings. Projects in the Clinical Sequencing Evidence-Generating Research (CSER) consortium enroll diverse racial/ethnic and medically underserved participants across various clinical contexts. This article explores a set of CSER results disclosure cases to expand the evidence base on experiences returning genomic results. Case details were collected using a structured set of questions. We identified common themes in the case set, and assessed challenges and strategies in achieving six relevant results disclosure objectives. CSER-affiliated patient/community stakeholder impressions of the findings were solicited via video conference calls. Seventeen cases across six CSER projects were included. Case themes sorted into four categories: (1) factors influencing participant understanding, (2) participant emotional response, (3) disease burden, and (4) logistical challenges. Challenges meeting results disclosure objectives included a lack of dialogue, health literacy level, unexpected findings, and complex concepts. Strategies were consistent with traditional genetic counseling practice, but also highlighted approaches being evaluated in CSER projects. Patient/community stakeholders supported the identified themes and provided additional suggestions to improve patient understanding and engagement. These experiences add valuable insights into adapting genomic results disclosure practices to best serve all patient populations.
Keywords: exome sequencing; genetic counseling; genome sequencing; genomic sequencing; return of results; underrepresented populations.
Conflict of interest statement
The authors declare no conflict of interest.
Figures


Similar articles
-
Integration of stakeholder engagement from development to dissemination in genomic medicine research: Approaches and outcomes from the CSER Consortium.Genet Med. 2022 May;24(5):1108-1119. doi: 10.1016/j.gim.2022.01.008. Epub 2022 Feb 25. Genet Med. 2022. PMID: 35227608 Free PMC article.
-
The Clinical Sequencing Evidence-Generating Research Consortium: Integrating Genomic Sequencing in Diverse and Medically Underserved Populations.Am J Hum Genet. 2018 Sep 6;103(3):319-327. doi: 10.1016/j.ajhg.2018.08.007. Am J Hum Genet. 2018. PMID: 30193136 Free PMC article.
-
Examining access to care in clinical genomic research and medicine: Experiences from the CSER Consortium.J Clin Transl Sci. 2021 Sep 14;5(1):e193. doi: 10.1017/cts.2021.855. eCollection 2021. J Clin Transl Sci. 2021. PMID: 34888063 Free PMC article.
-
The motivation and process for developing a consortium-wide time and motion study to estimate resource implications of innovations in the use of genome sequencing to inform patient care.Clin Transl Sci. 2024 Jan;17(1):e13635. doi: 10.1111/cts.13635. Epub 2023 Dec 8. Clin Transl Sci. 2024. PMID: 38064200 Free PMC article. Review.
-
Racial and ethnic differences in genetic counseling experiences and outcomes in the United States: A systematic review.J Genet Couns. 2020 Apr;29(2):147-165. doi: 10.1002/jgc4.1230. Epub 2020 Mar 6. J Genet Couns. 2020. PMID: 32144851
Cited by
-
Reducing Time to Diagnosis of Rare Genetic Diseases in a Medically Underserved Hispanic Population- Lessons Learned for Meaningful Engagement.Res Sq [Preprint]. 2023 Dec 13:rs.3.rs-3699740. doi: 10.21203/rs.3.rs-3699740/v1. Res Sq. 2023. Update in: J Neurodev Disord. 2024 Sep 9;16(1):52. doi: 10.1186/s11689-024-09560-x. PMID: 38168160 Free PMC article. Updated. Preprint.
-
Comparing the Diagnostic Yield of Germline Exome Versus Panel Sequencing in the Diverse Population of the Texas KidsCanSeq Pediatric Cancer Study.JCO Precis Oncol. 2024 Sep;8:e2400187. doi: 10.1200/PO.24.00187. JCO Precis Oncol. 2024. PMID: 39259914
-
Integration of stakeholder engagement from development to dissemination in genomic medicine research: Approaches and outcomes from the CSER Consortium.Genet Med. 2022 May;24(5):1108-1119. doi: 10.1016/j.gim.2022.01.008. Epub 2022 Feb 25. Genet Med. 2022. PMID: 35227608 Free PMC article.
-
How to communicate and what to disclose to participants in a recall-by-genotype research approach: a multistep empirical study.J Community Genet. 2024 Dec;15(6):615-630. doi: 10.1007/s12687-024-00733-8. Epub 2024 Sep 26. J Community Genet. 2024. PMID: 39325315 Free PMC article.
-
The Challenge of Genetic Variants of Uncertain Clinical Significance : A Narrative Review.Ann Intern Med. 2022 Jul;175(7):994-1000. doi: 10.7326/M21-4109. Epub 2022 Apr 19. Ann Intern Med. 2022. PMID: 35436152 Free PMC article. Review.
References
-
- Berg J.S., Amendola L.M., Eng C., Van Allen E., Gray S.W., Wagle N., Rehm H.L., DeChene E.T., Dulik M.C., Hisama F.M., et al. Processes and preliminary outputs for identification of actionable genes as incidental findings in genomic sequence data in the Clinical Sequencing Exploratory Research Consortium. Genet. Med. Off. J. Am. Coll. Med. Genet. 2013;15:860–867. doi: 10.1038/gim.2013.133. - DOI - PMC - PubMed
-
- Schwartz M.L.B., McCormick C.Z., Lazzeri A.L., Lindbuchler D.M., Hallquist M.L.G., Manickam K., Buchanan A.H., Rahm A.K., Giovanni M.A., Frisbie L., et al. A Model for Genome-First Care: Returning Secondary Genomic Findings to Participants and Their Healthcare Providers in a Large Research Cohort. Am. J. Hum. Genet. 2018;103:328–337. doi: 10.1016/j.ajhg.2018.07.009. - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources